Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Stefanizzi · SciRah

Researcher profile · Semantic Scholar

C. Stefanizzi

Share profile

C. Stefanizzi — researcher profile on SciRah

h-index: 12
Works: 50
Citations: 475

Most-cited papers

"Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia.
R. Latagliata, M. Breccia, I. Carmosino, L. Cannella +10 more
2010Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis55 citations
Semantic Scholar
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib.
Massimo Breccia, M. Muscaritoli, L. Cannella, C. Stefanizzi +2 more
2008Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis54 citations
Semantic Scholar
Comorbidities and FLT3‐ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients
M. Breccia, A. Frustaci, L. Cannella, C. Stefanizzi +8 more
2009Hematological Oncology47 citations
Semantic Scholar
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study.
F. De Angelis, M. Tosti, S. Capria, E. Russo +5 more
2015Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis36 citations
Semantic Scholar
Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients.
M. Breccia, M. D. De Propris, C. Minotti, C. Stefanizzi +5 more
2014Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis35 citations
Semantic Scholar
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells
M. Breccia, M. D. De Propris, C. Stefanizzi, Sara Raponi +7 more
2014Annals of Hematology24 citations
Semantic Scholar
Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: A single institution experience.
M. Breccia, L. Cannella, A. Frustaci, C. Stefanizzi +2 more
2008Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis23 citations
Semantic Scholar
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia
C. Girmenia, E. Russo, I. Carmosino, M. Breccia +6 more
2007Annals of Hematology22 citations
Semantic Scholar
Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib.
M. Breccia, L. Cannella, D. Diverio, Paola Streponi +5 more
2008Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis19 citations
Semantic Scholar
Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia
M. Breccia, C. Stefanizzi, L. Cannella, R. Latagliata +4 more
2008Leukemia and Lymphoma17 citations
Semantic Scholar
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard dose
M. Breccia, L. Cannella, C. Stefanizzi, R. Latagliata +5 more
2009Hematological Oncology16 citations
Semantic Scholar
Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection.
S. Panfilio, P. D’Urso, G. Annechini, G. D'Elia +3 more
2013Leukemia Research Reports15 citations Open access
Semantic Scholar
Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?
Massimo Breccia, L. Cannella, C. Stefanizzi, A. Carotti +2 more
2009Bone Marrow Transplantation10 citations
Semantic Scholar
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
M. Breccia, M. Martelli, L. Cannella, E. Russo +5 more
2008Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis10 citations
Semantic Scholar
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia
Marta Chisini, C. Stefanizzi, Teresa Ceglie, Sara Raponi +16 more
2017Hematological Oncology9 citations
Semantic Scholar
Unusual association of paroxysmal cold hemoglobinuria as the first sign of disease in myelodysplastic patient
C. Stefanizzi, M. Breccia, Michelina Santopietro, S. Coluzzi +3 more
2009International journal of hematology9 citations
Semantic Scholar
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
M. Breccia, A. Frustaci, L. Cannella, S. Soverini +5 more
2009Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Nilotinib Can Override Dasatinib Resistance in Chronic Myeloid Leukemia Patients with Secondary Resistance to Imatinib First-Line Therapy
M. Breccia, L. Cannella, M. Nanni, C. Stefanizzi +1 more
2007Acta Haematologica9 citations
Semantic Scholar
Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: Further evidence for the arbitrary nature of current classification systems
M. Breccia, L. Cannella, A. Frustaci, C. Stefanizzi +2 more
2008Leukemia and Lymphoma8 citations
Semantic Scholar
Pregnancy in patients with myelodysplastic syndromes (MDS).
Paola Volpicelli, R. Latagliata, Massimo Breccia, I. Carmosino +6 more
2007Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis8 citations
Semantic Scholar
WPSS versus simplified myelodysplastic syndrome risk score: Which is the best tool for prediction of survival in myelodysplastic patients?
M. Breccia, L. Cannella, C. Stefanizzi, R. Latagliata +3 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations
Semantic Scholar
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
Massimo Breccia, R. Latagliata, L. Cannella, I. Carmosino +5 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations
Semantic Scholar
Occurrence of colon adenocarcinoma in chronic myeloid leukemia patients treated with imatinib: report of two cases and review of the literature.
A. Frustaci, Massimo Breccia, L. Cannella, C. Stefanizzi +1 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations
Semantic Scholar
Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance
L. Cannella, M. Breccia, C. Stefanizzi, L. Napoleone +2 more
2009Leukemia and Lymphoma4 citations
Semantic Scholar
Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose
M. Breccia, D. Cilloni, L. Cannella, C. Stefanizzi +5 more
2009Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar
Differences in Haematological and Non Haematological Toxicity during Treatment with Imatinib in Early and Late Chronic Phase Chronic Myeloid Leukemia Patients
M. Breccia, R. Latagliata, L. Cannella, I. Carmosino +3 more
20084 citations
Semantic Scholar
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients
S. Capria, S. Trisolini, C. Minotti, C. Stefanizzi +9 more
2012Mediterranean Journal of Hematology and Infectious Diseases3 citations Open access
Semantic Scholar
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
M. Breccia, L. Cannella, C. Stefanizzi, Michelina Santopietro +3 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
Treatment with Imatinib in Very Elderly (> 75 Years) CML Patients.
Roberto Latagli Ata, M. Breccia, S. Sica, A. Spadea +9 more
20082 citations
Semantic Scholar
Treatment Of Early Stage Follicular Lymphoma With Involved Field Radiotherapy and Rituximab. Role Of Bcl-2 Molecular Monitoring
I. Della Starza, P. D’Urso, G. D'Elia, G. Annechini +6 more
20131 citations
Semantic Scholar
ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN PATIENTS AGED > 70 Years.
P. Finsinger, M. Breccia, C. Minotti, I. Carmosino +8 more
20091 citations
Semantic Scholar
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results
R. Latagliata, A. Rago, A. Spadea, C. Santoro +11 more
2009International journal of hematology1 citations
Semantic Scholar
P106 High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes
R. Latagliata, E. Oliva, P. Volpicelli, L. Napoleone +8 more
20091 citations
Semantic Scholar
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas
F. Autore, A. Fresa, I. Innocenti, M. D. del Principe +14 more
2022Hematological Oncology0 citations
Semantic Scholar
Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022
Elisa Emanueli Cippitelli, Vincenza Innocenti, G. de Angelis, S. Bertelli +18 more
2022Blood0 citations Open access
Semantic Scholar
ОПТИМІЗАЦІЯ СХЕМ ЗАМІСНОЇ ТЕРАПІЇЇ ІМУНОГЛОБУЛІНАМИ ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ ХВОРИХ НА В-КЛІТИННИЙ ХРОНІЧНИЙ ЛІМФОЦИТАРНИЙ ЛЕЙКОЗ/ЛІМФОМУ З МАЛИХ ЛІМФОЦИТІВ
Serhutina Yu, P. Strati, T. Shanafelt, T. Kipps +63 more
2021Hematology & blood transfusion: interdepartamental collection0 citations Open access
Semantic Scholar
Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects
M. Mancini, Teresa Ceglie, S. Capria, A. Testi +16 more
20140 citations Open access
Semantic Scholar
Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia
M. Breccia, M. D. De Propris, M. D'Angiò, C. Stefanizzi +16 more
20140 citations
Semantic Scholar
Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia
Teresa Ceglie, Marta Chisini, F. Vozella, G. Colafigli +16 more
20140 citations
Semantic Scholar
Splenectomy Is Still a Valid Option For Splenic Marginal Zone Lymphoma
A. Pulsoni, P. D’Urso, G. D'Elia, G. Annechini +5 more
20130 citations
Semantic Scholar
Ara-C, Idarubicine and Gentuzumab Advanced Acute Myeloid Leukemia Patients
S. Capria, S. Trisolini, Clara Minotti, C. Stefanizzi +6 more
20120 citations
Semantic Scholar
ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN VERY ELDERLY PATIENTS (G 70 YEARS)
R. Latagliata, P. Finsinger, M. Breccia, C. Minotti +8 more
20100 citations
Semantic Scholar
Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia: How Important is the Achievement of Complete Cytogenetic Response after 3 Months?
R. Latagliata, M. Breccia, I. Carmosino, F. Vozella +7 more
20090 citations
Semantic Scholar
P016 Revised WHO 2008 classification of patients with RCUD (refractory cytopenia with unilineage dysplasia)
M. Breccia, R. Latagliata, L. Cannella, F. Gioiosa +6 more
20090 citations
Semantic Scholar
Platelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French–American–British and World Health Organisation classifications
M. Breccia, G. D'Elia, L. Cannella, C. Stefanizzi +4 more
2009Leukemia and Lymphoma0 citations
Semantic Scholar
P066 Familiar occurrence of myelodysplastic sydrome with del(5q)
L. Napoleone, R. Latagliata, M. Breccia, F. Vozella +8 more
20090 citations
Semantic Scholar
Prognostic Relevance of Retrospective WHO Re-Classification in 650 MDS Patients Diagnosed by FAB Criteria
M. Breccia, R. Latagliata, L. Cannella, I. Carmosino +3 more
20080 citations
Semantic Scholar
Comorbidities and FLT3 Abnormalities as Independent Prognostic Indicators of Survival in Elderly Acute Myeloid Leukemia Patients
M. Breccia, R. Latagliata, L. Cannella, I. Carmosino +3 more
20080 citations
Semantic Scholar
Phenotypic and molecular features of acute promyelocytic leukemia patients developing retinoic acid syndrome
M. Breccia, R. Latagliata, I. Carmosino, L. Cannella +7 more
20070 citations
Semantic Scholar
P100 Retrospective WHO re-classification of 650 MDS patients diagnosed by FAB criteria: prognostic relevance
M. Breccia, F. Gentilini, C. Stefanizzi, F. Natalino +3 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Breccia×36
Invite
M. Breccia — researcher profile on SciRah
G. Alimena×32
Invite
G. Alimena — researcher profile on SciRah
L. Cannella×28
Invite
L. Cannella — researcher profile on SciRah
R. Latagliata×27
Invite
R. Latagliata — researcher profile on SciRah

×16

Invite

I. Carmosino — researcher profile on SciRah

Michelina Santopietro×16

Invite

Michelina Santopietro — researcher profile on SciRah

Invite

D. Diverio — researcher profile on SciRah

Invite

F. Vozella — researcher profile on SciRah

A. Frustaci×11

Invite

A. Frustaci — researcher profile on SciRah

Invite

R. Foà — researcher profile on SciRah

M. D. De Propris×9

Invite

M. D. De Propris — researcher profile on SciRah

Invite

C. Minotti — researcher profile on SciRah